BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11955599)

  • 1. Recognition of immunoglobulins by Fcgamma receptors.
    Radaev S; Sun P
    Mol Immunol; 2002 May; 38(14):1073-83. PubMed ID: 11955599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of a human type III Fcgamma receptor in complex with Fc.
    Radaev S; Motyka S; Fridman WH; Sautes-Fridman C; Sun PD
    J Biol Chem; 2001 May; 276(19):16469-77. PubMed ID: 11297532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors.
    Radaev S; Sun PD
    J Biol Chem; 2001 May; 276(19):16478-83. PubMed ID: 11297533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.
    Sondermann P; Kaiser J; Jacob U
    J Mol Biol; 2001 Jun; 309(3):737-49. PubMed ID: 11397093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM; Kiyoshi M; Tsumoto K
    Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.
    Ferrara C; Grau S; Jäger C; Sondermann P; Brünker P; Waldhauer I; Hennig M; Ruf A; Rufer AC; Stihle M; Umaña P; Benz J
    Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12669-74. PubMed ID: 21768335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.
    Lu J; Sun PD
    Immunol Rev; 2015 Nov; 268(1):192-200. PubMed ID: 26497521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of Fcγ receptor I and its implication in high affinity γ-immunoglobulin binding.
    Lu J; Ellsworth JL; Hamacher N; Oak SW; Sun PD
    J Biol Chem; 2011 Nov; 286(47):40608-13. PubMed ID: 21965667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.
    Anthony RM; Ravetch JV
    J Clin Immunol; 2010 May; 30 Suppl 1():S9-14. PubMed ID: 20480216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the role of glycosylation in the structure of human IgG Fc.
    Borrok MJ; Jung ST; Kang TH; Monzingo AF; Georgiou G
    ACS Chem Biol; 2012 Sep; 7(9):1596-602. PubMed ID: 22747430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding.
    Lu J; Chu J; Zou Z; Hamacher NB; Rixon MW; Sun PD
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):833-8. PubMed ID: 25561553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans.
    Mizushima T; Yagi H; Takemoto E; Shibata-Koyama M; Isoda Y; Iida S; Masuda K; Satoh M; Kato K
    Genes Cells; 2011 Nov; 16(11):1071-80. PubMed ID: 22023369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors.
    Isoda Y; Yagi H; Satoh T; Shibata-Koyama M; Masuda K; Satoh M; Kato K; Iida S
    PLoS One; 2015; 10(10):e0140120. PubMed ID: 26444434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the murine unglycosylated IgG1 Fc fragment.
    Feige MJ; Nath S; Catharino SR; Weinfurtner D; Steinbacher S; Buchner J
    J Mol Biol; 2009 Aug; 391(3):599-608. PubMed ID: 19559712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Structural Role of Antibody N-Glycosylation in Receptor Interactions.
    Subedi GP; Barb AW
    Structure; 2015 Sep; 23(9):1573-1583. PubMed ID: 26211613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
    Bruggeman CW; Dekkers G; Bentlage AEH; Treffers LW; Nagelkerke SQ; Lissenberg-Thunnissen S; Koeleman CAM; Wuhrer M; van den Berg TK; Rispens T; Vidarsson G; Kuijpers TW
    J Immunol; 2017 Jul; 199(1):204-211. PubMed ID: 28566370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa.
    Sakae Y; Satoh T; Yagi H; Yanaka S; Yamaguchi T; Isoda Y; Iida S; Okamoto Y; Kato K
    Sci Rep; 2017 Oct; 7(1):13780. PubMed ID: 29062024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan.
    Falconer DJ; Subedi GP; Marcella AM; Barb AW
    ACS Chem Biol; 2018 Aug; 13(8):2179-2189. PubMed ID: 30016589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa.
    Ahmed AA; Keremane SR; Vielmetter J; Bjorkman PJ
    J Struct Biol; 2016 Apr; 194(1):78-89. PubMed ID: 26850169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.